HRG can also activate anchorage-independent breast cancer cell growth more potently than EGF, whilst the HRG-dependent activation of phosphatidylinositol-3-kinase (PI3K)/Akt pathway is a necessary event for cell transformation [50]. Here, AKT1 is linked to breast carcinoma.